News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Wednesday, October 22, 2014

Top Breaking News
Activist Investor Third Point Urges Amgen (AMGN) To Break Up
Job Cuts Loom Over GlaxoSmithKline (GSK) As It Aims To Cut Costs; Eyes IPO Of HIV Unit
Roche (RHHBY) To Spend $3.2 Billion On Basel Site Upgrade
Johnson & Johnson (JNJ) Pledges $200 Million To Ebola, Will Begin Testing Vaccine In January 2015
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Join Forces To Make Millions Of Ebola Vaccine Doses
Viamet Pharmaceuticals Withdraws $75 Million IPO, Spins Off Cancer Program To Form Innocrin Pharmaceuticals
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts
Regulus Therapeutics, Inc. (RGLS) Gets Seat At Hepatitis C Table With Impressive Phase 1 Results; Stock Up 99.98% At 12:54PM ET On Wednesday
Vertex Pharmaceuticals (MA) (VRTX) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion
Actavis (ACT) Pays $40 Million Upfront; Snags Option To Buy Rhythm Health
Lexicon Pharmaceuticals, Inc. (LXRX), Ipsen (IPN.PA) Strike Licensing Deal Worth $145 Million
Boston's Proteon Therapeutics, Inc. Files For $61 Million IPO
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda (TKPYY) Forge $55 Million Deal For Amitiza®
AcelRx Pharmaceuticals (ACRX)'s Zalviso Met Primary Endpoint In Phase 3 Study
Forendo Pharma Closes EUR 12 Million Series A Financing Round

Featured Stories

More News
Videregen Welcomes Launch Of Angels In MedCity
Santen Announces Positive Outcome Of The European Decentralized Procedure For Approval Of TAPTIQOM®
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval
Alkermes plc (ALKS)’ New Drug Application For Aripiprazole Lauroxil For Treatment Of Schizophrenia Accepted For Filing By U.S. FDA
Synageva BioPharma (GEVA) Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa
Relypsa, Inc. (RLYP) Submits New Drug Application To U.S. FDA Seeking Approval For Patiromer For Oral Suspension To Treat Hyperkalemia
Repros Therapeutics Inc. (RPRX) Release: Results From Long-Term Study Of Androxal® Exhibit Positive Safety Profile
Immune Pharmaceuticals, Inc. Release: New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease
GW Pharmaceuticals Announces Epidiolex® Receives Orphan Designation From European Medicines Agency For The Treatment Of Dravet Syndrome
Oramed Pharmaceuticals Inc. (ORMP) Reports Positive Top-Line Data From U.S. Phase 2a Trial With Oral Insulin In Type 1 Diabetes
Nuvo Research Inc. (NRI.TO) Completes WF10™ U.S. Market Study For Treatment Of Refractory Allergies
Atara Biotherapeutics (ATRA) Doses First Patient In Phase 1 Clinical Study Of STM 434, An Activin Inhibitor
iCo Therapeutics Inc. Announces Advancement Of Oral Amphotericin B Program
Phosplatin Therapeutics Announces First Patients Enrolled In Phase I First-in-Human Clinical Trial In Solid Tumors
University of Pittsburgh Study: Air Pollution Linked To Autism In Southwestern Pennsylvania
BioNano Genomics's Irys System Adopted By Leading Genomics Centers For Comprehensive Detection Of Human Genome Structural Variation
Ferring Pharmaceuticals To Acquire Marketing Rights For DDAVP® (desmopressin) Product Portfolio From Sanofi (SAN.PA)
Center For Connected Health And Daiichi Sankyo, Inc. (4568.t) Sign Agreement To Co-Develop A Mobile App To Support Patients With Atrial Fibrillation
PureMHC LLC Release: Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets
Masters Speciality Pharma Signs Exclusivity Agreement With Speciality European Pharma For The Exclusive Distribution Of Mitocin®/Mitem® 20mg (mitomycin)
Xbrane Bioscience Signs Major Biosimilar Agreement With Global Indian Pharmaceutical Company
Foundation Medicine, Inc. (FMI) And WuXi PharmaTech Co., Ltd. Announce Strategic Collaboration To Offer Best-In-Class Comprehensive Genomic Profiling In China
Terumo BCT And OneBlood Partner In A Treatment Use Program Of An Investigational Device To Help Improve Blood Supply Safety
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies
Daxor Corporation (DXR) Announces Research Agreement With Virginia Commonwealth University On Burn Patients
iBio, Inc. (IBIO) Expands Exclusive Product Collaboration With Novici Biotech
Quest PharmaTech Inc. To Market And Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator Of COLD FX®, To Assist
UCB Group (UCBJF.PK) Deploys IMS Health Nexxus Suite And Intelligent Cloud To Drive Commercial Productivity, Accelerate Time To Insight
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses
Tekmira (TKMR) Provides Periodic Update On TKM-Ebola Program
Synthetic Biologics, Inc. (SYN) Announces Allowance Of Key U.S. Composition Of Matter Patent For C. Difficile Program
Bioren, Inc. Announces Additional Orders For $1.7 Million
Amgen (AMGN) Statement Regarding Third Point Investment
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program
Mederi Therapeutics Inc. Release: Recent Clinical Study Data Confirms Efficacy Of Stretta Therapy - Spurs Additional Insurance Coverage And Financing Round
TapImmune Inc. (TPIV) Provides Update On Polystart™ Vaccine Platform Applicable To Cancer And Infectious Disease
EHE International Certifies Internal Medicine Consultants Of Northwest Indiana As Its Newest Partner
Metabolon's Platform For Clinical Triaging Of Inborn Errors Of Metabolism Verified By Baylor College of Medicine
Flexion Therapeutics (FLXN) To Ring The Nasdaq Stock Market Opening Bel
Clovis Oncology (CLVS) To Announce Third Quarter 2014 Financial Results And Host Webcast Conference Call On November 6
m2p-labs Supports Research Project In Synthetic Biology
New Class of MassCONNECT Startups Chosen Nixon Peabody LLP And Eli Lilly and Company (LLY) Sponsor
Prima Biomed (PRR.AX) To Host Conference Call & Webcast To Discuss Acquisition Of Immutep S.A.
Esperion Therapeutics, Inc. (ESPR) Announces Closing Of Follow-On Public Offering And Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock
Radiant Sage Announces Corelab-in-a-Box Version 3.1
Taconic Biosciences Launches New Health Standard
Crown Bioscience, Inc. Release: Crown Bioscience Service Center Opening At David H. Murdock Research Institute
Argos Therapeutics, Inc. (ARGS) Breaks Ground On State-Of-The-Art Biomanufacturing Facility In Research Triangle Park Area
Akron Biotechnology, LLC Expanding To New, State-of-the-Art Biotechnology Facility
Cytovance Biologics Inc. Announces the Launch Of Keystone Expression System™
Abbott Laboratories (ABT) Reports Third-Quarter 2014 Results
Abaxis, Inc. (ABAX) Reports Record Revenues For The Second Quarter Of Fiscal 2015
Biogen Idec (BIIB) Third Quarter 2014 Revenues Increase 37% To $2.5 Billion
Compugen Ltd. (CGEN) Third Quarter 2014 Conference Call Scheduled For Wednesday, October 29, 2014 At 10:00 AM ET
Cubist Pharmaceuticals, Inc. (CBST) Reports Third Quarter 2014 Financial Results
Cerus Corporation (CERS) To Release Third Quarter 2014 Results On November 4, 2014
ChemoCentryx, Inc. (CCXI) To Hold Third Quarter 2014 Financial Results Conference Call On Wednesday, November 5, 2014
Cempra Pharmaceuticals, Inc. To Report Third Quarter 2014 Financial Results And Host Webcast And Conference Call On October 29, 2014
Cumberland Pharmaceuticals (CPIX) To Announce Third Quarter 2014 Financial Results On November 4, 2014
Gilead Sciences, Inc. (GILD) To Release Third Quarter 2014 Financial Results On Tuesday, October 28, 2014
ICON Reports Third Quarter 2014 And Increases Earnings Guidance
Momenta Pharmaceuticals, Inc. (MNTA) Announces Date Of Third Quarter 2014 Financial Results Conference Call And Webcast
OXiGENE (OXGN) Announces Third Quarter 2014 Earnings Conference Call And Webcast
Orexo AB (ORXOF): Interim Report January-September 2014
Radius (RDUS) To Announce Third Quarter 2014 Financial Results, Host Conference Call And Live Webcast On Nov 11, 2014
St. Jude Medical (STJ) Announces Fourth Quarter Dividend
TRANSGENE (ENX:TNG) Announces Third Quarter 2014 Financial Results
Thermo Fisher Scientific (TMO) Reports Third Quarter 2014 Results
The Medicines Company (MDCO) Reports Third Quarter And First Nine Months 2014 Results
aTyr Pharma Inc. Appoints John C. McKew, Ph.D., As Vice President, Research
ProNAi Therapeutics, Inc. Strengthens Senior Management Team To Advance DNAi®-based Oncology Therapeutics
Glaucoma Foundation Holds Third Scientific Think Tank On Exfoliation Syndrome
Acceleron Pharma Announces Educational Webcast On Chronic Kidney Disease - Mineral And Bone Disorder
Creative Animodel Updated TALENs Services: Customized For Biotech Researchers And Developers
CD Genomics Release: FFPE Samples Sequencing For Genotyping Studies
Novo Nordisk Partners With Award-Winning Youtube Star Michael Stevens On New Online Videos For Diabetes Education
Celltrion, Inc. (068270.KQ): Experts Share Their “Real World” Experience Of Treating People With Inflammatory Bowel Disease (IBD) With Biosimilar Anti-Tnfa Monoclonal Antibody (Mab)
Opexa Therapeutics (OPXA) Supports National Multiple Sclerosis Society And Walk MS
GlaxoSmithKline (GSK) CEO And CFO Interviewed On 2014 Q3 Results
Frost & Sullivan Recognises Europe's Top Achievers At Excellence In Best Practices Awards Banquet In Monaco
Colorado BioScience Association Announces Finalists For 2014 ‘Company Of The Year’ And ‘Rising Star’ Of The Year Awards
Fogarty Institute for Innovation Release: Dr. Thomas J Fogarty Awarded Presidential National Medal Of Technology And Innovation
UCB, Inc. (UCBJF.PK)-sponsored Data On Cimzia® (certolizumab pegol) To Be Highlighted At American College of Gastroenterology 2014 Annual Scientific Meeting
GenomOncology President And CEO Manuel Glynias To Present At Cleveland Clinic’s 12th Annual Medical Innovation Summit
HealthMap Co-Founder And Prominent Epidemiologist Dr. John Brownstein To Deliver Keynote At 2014 mHealth Summit Focused On Ebola Outbreak, Epidemics And Public Health Surveillance
Leading Biobased Business Experts To Discuss What’s Next In Industrial Biotechnology And The Bioeconomy At The Biotechnology Industry Organization (BIO) 2014 Pacific Rim Summit
Novalis: Industry Leaders Present The Technical And Clinical Validation Of Integrated Surgery And Radiosurgery For Benign Brain Tumors
BioFlorida, Inc. Conference Promotes Collaboration, Growth And Innovation In Florida’s Life Sciences Industry
Gateway Analytical To Present On Formulation Development And Establishing Bioequivalence In Drug Products
McKesson Corporation To Present At The 2014 Credit Suisse Healthcare Conference
Acceleron Pharma Announces Educational Webcast On Chronic Kidney Disease - Mineral And Bone Disorder
Theorem Clinical Research To Present Webinar On Best Practices For Conducting Early-Phase Oncology Trials
Epilepsy Foundation Release: Conference Highlights Sudden Unexpected Death In Epilepsy (SUDEP)
Reproductive Medicine Associates Release: New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies
The 65th Annual Meeting Of The American Association For The Study Of Liver Diseases
Cellular Dynamics International To Present At The 2014 Medical Innovation Summit
RedHill Biopharma Ltd. (RDHL) To Present At The 20th Annual BIO-Europe International Partnering Conference
Immunomedics, Inc. (IMMU) To Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates At Upcoming Conferences